Recruiting NA Hearing Loss, Sensorineural

New treatment option for Hearing Loss, Sensorineural

Official title Barriers and Facilitators to OTC Hearing Aids Success

ClinicalTrials.gov ID: NCT06499805

What this study is testing

What it's testing
Hearing aids can improve hearing, communication, and overall quality of life for people with hearing loss. However, not many people use hearing aids.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 89

You may be able to join if

  • adult-onset, perceived bilateral mild-to-moderate hearing loss
  • no previous hearing aid experience

You likely can't join if

  • Non-native speaker of English

The study team makes the final eligibility decision.

Where it's taking place

  • Iowa City, Iowa, United States
  • Nashville, Tennessee, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Iowa City, Iowa, United States; Nashville, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.